Turner syndrome — branching viva

Opening framework

My framework has four layers. First, the diagnosis — Turner syndrome is the complete or partial loss of one X chromosome in a phenotypic female, confirmed by a peripheral blood karyotype, and the presentation is age-dependent: cystic hygroma in the fetus, lymphoedema in the newborn, short stature in the child, and delayed puberty in the adolescent. Second, the mechanism — haploinsufficiency of genes that escape X-inactivation, chief among them SHOX on Xp, which builds the skeleton, and the lymphogenic genes, which build the neck. Third, the management — growth hormone for stature, timed oestrogen for puberty and bone, cardiovascular surveillance for the aorta, and psychosocial and reproductive support. Fourth, the lifespan — the transition to adult care and the pregnancy aortic-dissection risk, which are where the preventable deaths occur. [1] [2]

The diagnosis and the pathophysiology

This girl's combination of short stature, absent puberty, the stigmata of SHOX haploinsufficiency (cubitus valgus, low posterior hairline), a left-sided cardiac murmur, and hypergonadotrophic hypogonadism is classic Turner syndrome, and the diagnostic test is a peripheral blood karyotype. The pathophysiology of her stature is haploinsufficiency of the SHOX gene in the pseudoautosomal region of Xp: SHOX escapes X-inactivation, governs chondrocyte proliferation in the growth plate, and its loss produces the short stature and the skeletal stigmata. Her hypergonadotrophic hypogonadism reflects accelerated follicular atresia in the streak ovaries, which are fibrous and devoid of follicles by early childhood. The elevated FSH and low oestradiol confirm the gonadal failure. [2] [1]

The management framework

Management is a five-domain framework. Growth hormone is started early — the Canadian randomised trial showed an approximate 5 to 7 cm gain in adult height — and continued to near-final height, with adjunctive oxandrolone in some protocols. Oestrogen induction begins at about 11 to 12 years at low dose, titrated over two to three years, with progestogen added for endometrial protection and uterine priming, which matters for future fertility options. Cardiovascular surveillance with echocardiography and cardiac MRI defines and monitors the aortic anatomy, with lower dissection and surgery thresholds than the general population. The renal, audiological, and thyroid surveillance complete the medical map, and psychosocial and reproductive counselling runs alongside from adolescence. [3] [1]

Branch: the four-year-old with 45,X/46,XY mosaicism

For the four-year-old whose karyotype is 45,X/46,XY mosaicism, the key point is the gonadoblastoma risk. The Y-bearing dysgenetic streak gonad carries a materially elevated risk of gonadoblastoma, a carcinoma in situ, and the international guideline recommends prophylactic gonadectomy once the diagnosis is confirmed. The gonadectomy removes the cancer risk and also removes the source of any residual androgen or oestrogen that could confound the pubertal management; she will then need oestrogen replacement from the normal age of induction. I counsel the parents honestly, explain that the surgery is preventive and removes the risk, and offer genetic and psychosocial support. [1] [8]

Branch: the 30-year-old seeking fertility

For the 30-year-old with Turner syndrome seeking fertility, the conversation is dual. First, the fertility itself: the overwhelming majority of women with Turner syndrome are infertile due to streak ovaries, but a small minority — mostly mosaics — retain enough follicles for spontaneous pregnancy, and oocyte donation offers pregnancy to the rest. Second, and the safety-critical point, the aortic-dissection risk in pregnancy is substantially elevated and is a leading cause of maternal death in Turner syndrome. Every pregnancy attempt requires dedicated cardio-obstetric input, a pre-pregnancy cardiac MRI, and an explicit risk discussion, because pregnancy is one of the highest-risk periods in a Turner lifespan. [4] [1]

Closing: the transition and the trap to avoid

The closing point is the transition cliff and the classic trap. The structured transition from paediatric to adult care — with a named adult endocrinologist and cardiologist, a reconciled summary, and explicit aortic-imaging and bone-density plans — is the intervention that prevents the preventable deaths, because the excess mortality is concentrated in young and middle adulthood and is driven by aortic dissection and ischaemic heart disease. The trap is to treat the Turner aorta with generic population thresholds: the Turner aorta is intrinsically abnormal, dissects at smaller dimensions, and requires lower surgery thresholds. The plan is shared and documented, and the aortic imaging never lapses. [8] [1]